Check out Associate Editor David Herman's range review of Leupold's Second Generation VX-5HD riflescope.

Nanoscope Therapeutics is on the brink of filing what could be the first mutation-agnostic gene therapy for incurable eye disease retinitis pigmentosa.

Nanoscope Therapeutics has reported data from a mid-stage clinical trial that suggests its optogenetic therapy based on light-sensitive molecules is an effective treatment for incurable eye ...

Yahoo Finance is chronicling the latest news and updates on Trump's tariffs.